Blood recycling after bypass heart surgery
Part of Heart & circulation clinical trials.
This trial tests whether collecting and re-infusing your own blood during heart surgery reduces the need for donor blood transfusions. It's for adults having planned bypass surgery with a heart-lung machine.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old.
- You are scheduled for planned (not emergency) coronary artery bypass surgery using a heart-lung machine.
- You are not having any other heart procedures at the same time, like valve repair or aortic surgery.
- Your red blood cell level (hematocrit) is 30% or higher before surgery.
- You do not have any bleeding disorders, severe kidney or liver problems, or active infections or cancer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving back a patient's own platelets and red blood cells during heart surgery can reduce bleeding and the need for donor blood transfusions. It is for people having certain types of high-risk heart surgery with a heart-lung machine.
This trial looks at how a device that collects and reuses your own blood during heart surgery works. It may help reduce the need for donated blood.
This trial studies giving a “fresh” blood transfusion from your own blood after heart surgery that uses a heart-lung machine. It may help patients avoid needing donated blood, but it only works for people who meet specific safety and timing requirements.
This study looks at how much donated blood (blood products) is needed for younger adults during heart surgery that uses a heart-lung machine. It may help doctors choose safer, more appropriate blood-saving plans for people like you.
This study tests whether giving blood transfusions based on each patient's needs during and after heart surgery is safe and effective. It compares different transfusion thresholds to see which works better.
This study looks at certain blood and bone marrow cells (megakaryocytes) in people having heart bypass surgery. It aims to learn more about these cells, which may help in future treatments.
Hear when a new Coronary artery disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.